Stratipath Breast AI-based risk profiling for breast cancer is now available for clinical use in the UK.
Stratipath Breast, is now officially registered with the Medicines and Healthcare products Regulatory Agency (MHRA). This registration allows healthcare providers across the United Kingdom access to the AI-based prognostic tool for breast cancer risk profiling.
